Covid Vaccines May Only Stop Covid Symptoms: Yuen
"); jQuery("#212 h3").html("

"); });
2020-12-25 HKT 13:52
Government adviser Yuen Kwok-yung said on Friday that the three types of coronavirus vaccines procured by the government may not be able to help Hong Kong avoid asymptomatic infections, but he stressed there is still an urgent need for everyone to get inoculated.
The University of Hong Kong microbiologist explained that early lab tests showed the vaccines could trigger the production of neutralizing antibodies to prevent a person from developing symptoms or complications after being infected, but they could not stop a person from releasing the virus and infecting others.
Still, Yuen highlighted that efforts to help Hong Kong develop herd immunity should get underway as soon as possible.
"There is an imminent need to launch a universal innoculation programme," Yuen wrote with his research team in the Chinese-language Ming Pao newspaper.
Yuen, who is a member of the government's independent advisory panel on Covid-19 vaccines, also suggested that vaccines produced by Fosun-BioNtech and the mainland's Sinovac could be better options to be introduced in Hong Kong first.
He noted that trial results out so far for the Sinovac vaccine showed that it carries the fewest side-effects, but is expected to offer a shorter protection period.
But he stressed that the government must wait for Sinovac's late-stage trial results, which will not be released until next month after a delay, and conduct a thorough analysis before deciding to use its vaccine.
As for the vaccine developed by Fosun and BioNTech, Yuen said clinical trials showed that it is relatively safe and also offers good protection.
But he said it is necessary to observe the third option by Oxford University and AstraZeneca for a longer period of time for any side effects, noting that two people who earlier received the jabs had developed a neurological disorder.
Yuen urged the government to boost public confidence in inoculating against the coronavirus by being transparent.
"The inoculation scheme must aim to be quick, widespread, open and with choices for people to pick," he said.
Ant International And Bank Of China Partner To Enhance Cross-Border Payment Connectivity
Ant International and Bank of China (Hong Kong) (“BOCHK”) announced a partnership which leverages BOCHK’s banking... Read more
BitGo Korea Gets Green Light For Virtual Asset Custody, Backed By SK Telecom
BitGo Holdings, Inc. (BitGo) announced that its subsidiary, BitGo Korea, Inc. (BitGo Korea), received its Virtual Asset... Read more
Webinar: When Account Takeover Moves Past Onboarding
Account takeover shows why fraud risk cannot be treated as an onboarding problem. Fraudsters are using stolen credentia... Read more
JCB To Trial Stablecoin Payments In Japan With Digital Garage And Lawson
JCB Co., Ltd. (JCB), Digital Garage, Inc. (Digital Garage), and Lawson, Inc. (Lawson) announced that they have jointly ... Read more
Bonnie Chan To Lead HKEX Until Feb 2030 After Securing Second Term
The HKEX Board of Directors has approved the renewal of the employment contract of Hong Kong Exchanges and Clearing Lim... Read more
Ripple Signs Its First Korean Regional Bank In Cross-Border Remittance Deal
Ripple, a blockchain-based enterprise solutions provider for traditional and digital finance, announced a partnership w... Read more
